ADECATUMUMAB
UNII 000705ZASD

Substance Identification & Data

This profile provides standardized clinical and technical data for Adecatumumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 000705ZASD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 503605-66-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
000705ZASD
CAS Registry Number
503605-66-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ADECATUMUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
8449
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Adecatumumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ADECATUMUMAB

Common Names & Synonyms

ADECATUMUMAB [INN]
ADECATUMUMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN ANTIGEN 17-1A) (HUMAN MONOCLONAL MT201 G1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MT201 K-CHAIN, DIMER

Technical Codes

MT-201